ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 330.60
+7.60 (2.35%)
Apr 15, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 5.62 billion as of April 15, 2026. Its market cap has decreased by -38.48% in one year.
Market Cap
5.62B
Enterprise Value
5.35B
Revenue
493.12M
Ranking
n/a
PE Ratio
31.76
Stock Price
330.60
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 5.62B, an increase of 1,401.00%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 5.62B | -53.02% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 110.23B |
| Coloplast | 95.67B |
| ALK-Abelló | 47.68B |
| H. Lundbeck | 38.62B |
| Zealand Pharma | 20.37B |
| Ambu A/S | 17.38B |
| Bavarian Nordic | 15.27B |